Melatonin, Neuroprotective Agents and Antidepressant Therapy - Image 1

£162.72

Springer Melatonin, Neuroprotective Agents and Antidepressant Therapy

Name: Melatonin, Neuroprotective Agents and Antidepressant Therapy
Brand: Springer
Price: 162.72 GBP
Availability: InStock

Depression

It has never been this cheap. We have no record of a lower price.

£163 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 55 days · 55 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 55 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £168 (40 days, 72.7%)

Price range: £163 - £168

Price levels: 2 different prices over 55 days

Description

This work is a guidebook for clinicians who are involved in treating depressive patients and also serves the research scientists who are working on the psychopharmacological mechanisms of antidepressant actions and psychopathological mechanisms underlying mood disorders. Mood disorders such as major depressive disorder (MDD), bipolar disorder (BPD) and seasonal affective disorder (SAD) are the most disabling disorders that are among the most expensive of all medical illnesses. The pathophysiology of mood disorders is very complex and involves many mechanisms like circadian rhythm disruption, sleep abnormalities, melatonin rhythm abnormalities and alterations in melatonin receptor mechanisms, abnormalities in monoaminergic neurotransmitter mechanisms, glutamatergic release mechanisms, hippocampal neurogenesis, and abnormal immune and cytokine release mechanisms. Many antidepressants that are in clinical use today including the recently introduced novel agentslike agomelatine or other antidepressants cause clinical remission by resynchronizing disrupted circadian rhythms and melatonin receptor functions, enhancing monoaminergic neurotransmission, promoting hippocampal neurogenesis, and regulating immune mechanisms. This book explains various etiological factors that are involved in the pathogenesis of mood disorders and the mechanisms of therapeutic actions of antidepressants including the recently introduced agomelatine and other antidepressants that exhibit rapid onset of action with greater efficacy and fewer side effects. .

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 8132228014
Category: Books > Subjects > Health, Family & Lifestyle > Health Issues > Illnesses & Conditions > Depression
Domain: Amazon UK
Release Date: 19 June 2016
Listed Since: 03 March 2016

Barcode

No barcode data available

Springer Melatonin, Neuroprotective Agents and Antidepressant Therapy

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Neuro-Psychopharmaka Ein Therapie-Handbuch: Band 3: Antidepressiva, Phasenprophylaktika und Stimmungsstabilisierer

Evidence-biased Antidepressant Prescription: Overmedicalisation, Flawed Research, and Conflicts of Interest

Antidepressants (Milestones in Drug Therapy)

Neurobiology of Depression: Road to Novel Therapeutics

Major Depressive Disorder: Risk Factors, Characteristics & Treatment Options (Psychiatry - Theory, Applications and Treatments)

Antidepressants: Types, Efficiency & Possible Side Effects (Depression-Causes, Diagnosis, and Treatment)

Antidepressants: Past, Present and Future: 157 (Handbook of Experimental Pharmacology, 157)

Integrative Therapies for Depression: Redefining Models for Assessment, Treatment and Prevention

Antidepressants: Past, Present and Future: 157 (Handbook of Experimental Pharmacology, 157)

Pharmacotherapy For Depression And Treatment-Resistant Depression

Differenzierte Therapie mit trizyklischen Antidepressiva

Antidepressants: New Pharmacological Strategies (Contemporary Neuroscience)

Antidepressants: New Pharmacological Strategies (Contemporary Neuroscience)

Prescriber's Guide: Antidepressants: Stahl's Essential Psychopharmacology

Integrative Therapies for Depression: Redefining Models for Assessment, Treatment and Prevention

Treatment-Resistant Mood Disorders

Prevention and Early Treatment of Depression Through the Life Course (Depression and Personality)

Pharmacotherapy of Depression

The Myth of Depression as Disease: Limitations and Alternatives to Drug Treatment (Contemporary Psychology)

Humana Mood and Anxiety Related Phenotypes in Mice - Vol 42

Clinical Handbook for the Management of Mood Disorders

The Neuroscience of Depression: Features, Diagnosis, and Treatment

Herbal Treatment of Major Depression: Scientific Basis and Practical Use (Clinical Pharmacognosy Series)

Molecular Psychiatry